yes, but the BOD needs to adaot a sweeping true cost cutting plan, down to $500k per month until they have 3 serious news items, record dose sales and a 55% fall in Q income is not going to cut it , that's a head fk.
We need:
- 3 treatments under NUB funding in Germany
- TGA approval
- UAE approval all this ASAP, before end of this month.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.005(0.46%) |
Mkt cap ! $20.33M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.08 | $1.08 | $10.44K | 9.712K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1827 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 9552 | 1 |
View Market Depth
| Last trade - 10.13am 31/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |